Literature DB >> 33747926

Development of a Machine Learning Model for Optimal Applicator Selection in High-Dose-Rate Cervical Brachytherapy.

Kailyn Stenhouse1,2, Michael Roumeliotis1,2,3, Robyn Banerjee3,4, Svetlana Yanushkevich5, Philip McGeachy1,2,3.   

Abstract

Purpose: To develop and validate a preliminary machine learning (ML) model aiding in the selection of intracavitary (IC) versus hybrid interstitial (IS) applicators for high-dose-rate (HDR) cervical brachytherapy.
Methods: From a dataset of 233 treatments using IC or IS applicators, a set of geometric features of the structure set were extracted, including the volumes of OARs (bladder, rectum, sigmoid colon) and HR-CTV, proximity of OARs to the HR-CTV, mean and maximum lateral and vertical HR-CTV extent, and offset of the HR-CTV centre-of-mass from the applicator tandem axis. Feature selection using an ANOVA F-test and mutual information removed uninformative features from this set. Twelve classification algorithms were trained and tested over 100 iterations to determine the highest performing individual models through nested 5-fold cross-validation. Three models with the highest accuracy were combined using soft voting to form the final model. This model was trained and tested over 1,000 iterations, during which the relative importance of each feature in the applicator selection process was determined.
Results: Feature selection indicated that the mean and maximum lateral and vertical extent, volume, and axis offset of the HR-CTV were the most informative features and were thus provided to the ML models. Relative feature importances indicated that the HR-CTV volume and mean lateral extent were most important for applicator selection. From the comparison of the individual classification algorithms, it was found that the highest performing algorithms were tree-based ensemble methods - AdaBoost Classifier (ABC), Gradient Boosting Classifier (GBC), and Random Forest Classifier (RFC). The accuracy of the individual models was compared to the voting model for 100 iterations (ABC = 91.6 ± 3.1%, GBC = 90.4 ± 4.1%, RFC = 89.5 ± 4.0%, Voting Model = 92.2 ± 1.8%) and the voting model was found to have superior accuracy. Over the final 1,000 evaluation iterations, the final voting model demonstrated a high predictive accuracy (91.5 ± 0.9%) and F1 Score (90.6 ± 1.1%).
Conclusion: The presented model demonstrates high discriminative performance, highlighting the potential for utilization in informing applicator selection prospectively following further clinical validation.
Copyright © 2021 Stenhouse, Roumeliotis, Banerjee, Yanushkevich and McGeachy.

Entities:  

Keywords:  decision-support tools; gynecologic brachytherapy; high-dose-rate brachytherapy; intracavitary brachytherapy (ICBT); machine learning; radiation oncology

Year:  2021        PMID: 33747926      PMCID: PMC7973285          DOI: 10.3389/fonc.2021.611437

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  28 in total

Review 1.  Cervix cancer brachytherapy: high dose rate.

Authors:  P Miglierini; J-P Malhaire; G Goasduff; O Miranda; O Pradier
Journal:  Cancer Radiother       Date:  2014-08-21       Impact factor: 1.018

2.  International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG).

Authors:  Akila N Viswanathan; Carien L Creutzberg; Peter Craighead; Mary McCormack; Takafumi Toita; Kailash Narayan; Nicholas Reed; Harry Long; Hak-Jae Kim; Christian Marth; Jacob C Lindegaard; Annmarie Cerrotta; William Small; Edward Trimble
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-22       Impact factor: 7.038

3.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.

Authors:  Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits
Journal:  Radiother Oncol       Date:  2006-01-05       Impact factor: 6.280

4.  The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.

Authors:  Christian Kirisits; Stefan Lang; Johannes Dimopoulos; Daniel Berger; Dietmar Georg; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

5.  Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.

Authors:  Christel N Nomden; Astrid A C de Leeuw; Marinus A Moerland; Judith M Roesink; Robbert J H A Tersteeg; Ina Maria Jürgenliemk-Schulz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-12       Impact factor: 7.038

6.  MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).

Authors:  Reyhaneh Nosrati; Abraam Soliman; Habib Safigholi; Masoud Hashemi; Matthew Wronski; Gerard Morton; Ana Pejović-Milić; Greg Stanisz; William Y Song
Journal:  Radiother Oncol       Date:  2018-09-19       Impact factor: 6.280

7.  American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.

Authors:  Akila N Viswanathan; Sushil Beriwal; Jennifer F De Los Santos; D Jeffrey Demanes; David Gaffney; Jorgen Hansen; Ellen Jones; Christian Kirisits; Bruce Thomadsen; Beth Erickson
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

8.  Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.

Authors:  Beth Erickson; Patricia Eifel; Jennifer Moughan; Jason Rownd; Thomas Iarocci; Jean Owen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-15       Impact factor: 7.038

9.  Differences in outcome for cervical cancer patients treated with or without brachytherapy.

Authors:  Johannes Karlsson; Ann-Charlotte Dreifaldt; Louise Bohr Mordhorst; Bengt Sorbe
Journal:  Brachytherapy       Date:  2016-11-09       Impact factor: 2.362

10.  Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.

Authors:  Akila N Viswanathan; Beth A Erickson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.